Very Rare Cancer Consortium Research Seminar
A variety of cancer clinicians and investigators and advocacy groups discuss ongoing research approaches to rare cancers.
Speakers
-
Andreas von Deimling, MD
Department of Neuropathology,
Institute of Pathology
University of Heidelberg
Clinical Cooperation Unit Neuropathology
German Cancer Research Center (DFKZ)"Tumor-Specific Methylation Patterns — A Convincing Approach to Precision Diagnosis"
-
Olivier Elemento, PhD
Professor; Director, Englander Institute for Precision Medicine
Associate Director, Institute for Computational Biomedicine Physiology and Biophysics Computational Biomedicine
Weill Cornell Medicine
Affiliate Member
New York Genome Center